Goldberg, D I <br/><br/>
Effect of RenaGel, a non-absorbed, calcium- and aluminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  Sep 1998 
 - 2303-10 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0931-0509 
<br/><br/><label>Standard No.: </label>10.1093/ndt/13.9.2303  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Calcium--blood<br/>Diet<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Kidney Failure, Chronic--blood<br/>Male<br/>Middle Aged<br/>Parathyroid Hormone--blood<br/>Phosphorus--blood<br/>Polyamines--administration & dosage<br/>Sevelamer